Skip Header

1 - 25 of 27 results for author:"Belmaker R.H." in Literature citations

Page of 2 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (3)

Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells.

Nahman S., Belmaker R.H., Azab A.N.

Innate Immun 18:447-458(2012) · Mapped (3)

Nicotinamide-N-methyltransferase (NNMT) in schizophrenia: genetic association and decreased frontal cortex mRNA levels.

Bromberg A., Lerer E., Udawela M., Scarr E., Dean B., Belmaker R.H., Ebstein R., Agam G.

Int. J. Neuropsychopharmacol. 15:727-737(2012) · Mapped (2)

Copy number variation of the SELENBP1 gene in schizophrenia.

Amar S., Ovadia O., Maier W., Ebstein R., Belmaker R.H., Mishmar D., Agam G.

Behav Brain Funct 6:40-40(2010) · Mapped (8)

Is phosphoadenosine phosphate phosphatase a target of lithium's therapeutic effect?

Shaltiel G., Deutsch J., Rapoport S.I., Basselin M., Belmaker R.H., Agam G.

J Neural Transm 116:1543-1549(2009) · Mapped (1)

Knockout mice in understanding the mechanism of action of lithium.

Agam G., Bersudsky Y., Berry G.T., Moechars D., Lavi-Avnon Y., Belmaker R.H.

Biochem. Soc. Trans. 37:1121-1125(2009) · Mapped (3)

Homozygote inositol transporter knockout mice show a lithium-like phenotype.

Bersudsky Y., Shaldubina A., Agam G., Berry G.T., Belmaker R.H.

Bipolar Disord 10:453-459(2008) · Mapped (6)

Human MIP synthase splice variants in bipolar disorder.

Shamir A., Shaltiel G., Mark S., Bersudsky Y., Belmaker R.H., Agam G.

Bipolar Disord. 9:766-771(2007) · UniProtKB (1)

Effects of valproate derivatives on human brain myo-inositol-1-phosphate (MIP) synthase activity and amphetamine-induced rearing.

Galit S., Shirley M., Ora K., Belmaker R.H., Galila A.

Pharmacol. Rep. 59:402-407(2007) · UniProtKB (1)

Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.

Amar S., Shaltiel G., Mann L., Shamir A., Dean B., Scarr E., Bersudsky Y., Belmaker R.H., Agam G.

Int. J. Neuropsychopharmacol. 11:197-205(2008) · Mapped (4)

Oxygen restriction of neonate rats elevates neuregulin-1alpha isoform levels: possible relationship to schizophrenia.

Nadri C., Belmaker R.H., Agam G.

Neurochem. Int. 51:447-450(2007) · Mapped (23)

No evidence for association between NOTCH4 and schizophrenia in a large family-based and case-control association analysis.

Ivo R., Schulze T.G., Schumacher J., Kesper K., Muller D.J., Kremer I., Dobrusin M., Mujaheed M., Murad I., Blanaru M. et al.

Psychiatr. Genet. 16:197-203(2006) · Mapped (6)

Behavioural phenotyping of sodium-myo-inositol cotransporter heterozygous knockout mice with reduced brain inositol.

Shaldubina A., Buccafusca R., Johanson R.A., Agam G., Belmaker R.H., Berry G.T., Bersudsky Y.

Genes Brain Behav. 6:253-259(2007) · Mapped (3)

SMIT1 haploinsufficiency causes brain inositol deficiency without affecting lithium-sensitive behavior.

Shaldubina A., Johanson R.A., O'Brien W.T., Buccafusca R., Agam G., Belmaker R.H., Klein P.S., Bersudsky Y., Berry G.T.

Mol. Genet. Metab. 88:384-388(2006) · Mapped (3)

Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: desire, arousal and sexual function.

Ben Zion I.Z., Tessler R., Cohen L., Lerer E., Raz Y., Bachner-Melman R., Gritsenko I., Nemanov L., Zohar A.H., Belmaker R.H. et al.

Mol. Psychiatry 11:782-786(2006) · Mapped (56)

Transmission disequilibrium and haplotype analyses of the G72/G30 locus: suggestive linkage to schizophrenia in Palestinian Arabs living in the North of Israel.

Korostishevsky M., Kremer I., Kaganovich M., Cholostoy A., Murad I., Muhaheed M., Bannoura I., Rietschel M., Dobrusin M., Bening-Abu-Shach U. et al.

Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B:91-95(2006) · Mapped (7)

Postmortem parietal cortex TPH2 expression is not altered in schizophrenic, unipolar-depressed, and bipolar patients vs control subjects.

Shamir A., Shaltiel G., Levi I., Belmaker R.H., Agam G.

J. Mol. Neurosci. 26:33-37(2005) · Mapped (3)

Valproate decreases inositol biosynthesis.

Shaltiel G., Shamir A., Shapiro J., Ding D., Dalton E., Bialer M., Harwood A.J., Belmaker R.H., Greenberg M.L., Agam G.

Biol. Psychiatry 56:868-874(2004) · Mapped (1)

GSK-3beta in cerebrospinal fluid of schizophrenia patients.

Kozlovsky N., Regenold W.T., Levine J., Rapoport A., Belmaker R.H., Agam G.

J Neural Transm 111:1093-1098(2004) · Mapped (5)

The effect of lithium on expression of genes for inositol biosynthetic enzymes in mouse hippocampus; a comparison with the yeast model.

Shamir A., Shaltiel G., Greenberg M.L., Belmaker R.H., Agam G.

Brain Res. Mol. Brain Res. 115:104-110(2003) · UniProtKB (1)

Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs.

Kremer I., Pinto M., Murad I., Muhaheed M., Bannoura I., Muller D.J., Schulze T.G., Reshef A., Blanaru M., Gathas S. et al.

Am. J. Med. Genet. B Neuropsychiatr. Genet. 119B:35-39(2003) · Mapped (7)

Relation of shyness in grade school children to the genotype for the long form of the serotonin transporter promoter region polymorphism.

Arbelle S., Benjamin J., Golin M., Kremer I., Belmaker R.H., Ebstein R.P.

Am J Psychiatry 160:671-676(2003) · Mapped (74)

Epi-inositol regulates expression of the yeast INO1 gene encoding inositol-1-P synthase.

Shaldubina A., Ju S., Vaden D.L., Ding D., Belmaker R.H., Greenberg M.L.

Mol. Psychiatry 7:174-180(2002) · Mapped (2)

No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population.

Kremer I., Rietschel M., Dobrusin M., Mujaheed M., Murad I., Blanaru M., Bannoura I., Muller D.J., Schulze T.G., Reshef A. et al.

Am. J. Med. Genet. 96:778-780(2000) · Mapped (6)

The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness.

Steen V.M., Lovlie R., Osher Y., Belmaker R.H., Berle J.O., Gulbrandsen A.K.

Pharmacogenetics 8:259-268(1998) · UniProtKB (1)

No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance.

Ebstein R.P., Gritsenko I., Nemanov L., Frisch A., Osher Y., Belmaker R.H.

Mol. Psychiatry 2:224-226(1997) · Mapped (3)

to top of page·

Page of 2 | Next »